Physician profile
Randall Rowand
NPI 1538130620
$1,090.56
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $796 · 2020: $261 · 2021: $33.63.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $150.03 | 2019 | |
| Novo Nordisk INC | $148.54 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $137.62 | 2019-2020 | |
| Biofire Diagnostics, LLC | $74.70 | 2019-2020 | |
| Glaxosmithkline, LLC. | $69.40 | 2019-2020 | |
| Amarin Pharma, INC. | $64.46 | 2019-2020 | |
| Pfizer INC. | $64.00 | 2019 | |
| Sanofi Pasteur INC. | $51.67 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $48.80 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.90 | 2019 | |
| Avanir Pharmaceuticals, INC. | $35.59 | 2019 | |
| Sanofi-Aventis U.S. LLC | $24.87 | 2019 | |
| Lilly USA, LLC | $22.37 | 2019 | |
| Amgen INC. | $18.46 | 2019 | |
| Harmony Biosciences LLC | $18.32 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $16.78 | 2020 | |
| Abbvie INC. | $16.34 | 2021 | |
| Allergan, INC. | $15.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.97 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $13.92 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.36 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.19 | 2019 | |
| Merck Sharp & Dohme LLC | $11.34 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Rowand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.